Wednesday, March 24, 2021
Regeneron Antibody Cocktail Cuts Hospitalization Rate by 70% - Bloomberg
Regeneron Antibody Cocktail Cuts Hospitalization Rate by 70% - Bloomberg: Regeneron Pharmaceuticals Inc. said it would apply for U.S. authorization for a lower dose of its Covid-19 antibody cocktail, after data from a final-stage trial showed early use of the drug reduced hospitalizations and deaths by 70%.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment